MedTrace Logo

Stress Hormones and IUDs

NCT03499379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2020-01-07

No results posted yet for this study

Summary

Determine what kind of side effects women experience in the first year after they start using an intrauterine device.

Conditions

  • Contraception
  • Mood Change

Interventions

DEVICE

Mirena

A radio-opaque T-shaped polyethylene device containing 52mg of levonorgestrel dispersed in polydimethylsiloxane on its stem. The progestin is released at a rate of 15 mcg per day.

DEVICE

Paraguard

A T-shaped polyethylene device with 380 mm2 of exposed surface area of fine copper wire wound around its arms and stem. Barium sulfate has been added to the polyethylene frame to make the device radio-opaque. A 3-mm plastic ball is located at the base of the IUD, through which the polyethylene monofilament string passes.

Sponsors & Collaborators

Principal Investigators

  • Nora Doty, MD · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-16
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499379 on ClinicalTrials.gov